Founded in 2021, Genomines is a deeptech startup that uses biotechnology to reinvent the mining industry.
This funding will enable Genomines to (...)
Press Release
Paris, 4 November 2025
Plasseraud IP welcomes Jérémie Palacci as Partner and strengthens its expertise in Artificial Intelligence and (...)
Guylène Kiesel Le Cosquer
Our experts, Guylène Kiesel Le Cosquer, Partner and Board Member, and Ina Schreiber, Partner and Head of the Patent Department, represent Plasseraud (...)
On October 22, 2025, the biopharmaceutical group Ipsen announced that it had entered into a definitive agreement to acquire ImCheck Therapeutics, a (...)
Plasseraud IP is proud to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina Schreiber have once again been ranked among the best (...)
On October 23, 2025, Vincent Girard and Seowon PARK, experts at Plasseraud IP, represented the firm at the conference organized by the FKCCI (French (...)
The IAM Strategy 300: The World’s Leading IP Strategists identifies professionals who stand out for their strategic vision and ability to maximize (...)
Guylène Kiesel Le Cosquer, Laurence Loumes, Atsuya Takeshita, Atom Tong, Partners, Isabelle Labarre, European Patent Attorney at Plasseraud IP, and (...)
Plasseraud IP took part in the inaugural UN Citiverse Challenge, organized by the United Nations and World Intellectual Property Organization – (...)
Since January 19, 2025, filing a continuing patent application (continuation, divisional, or continuation-in-part) with the USPTO requires the (...)